GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India · Delayed Price · Currency is INR 2,524.85
+24.15 (0.97%)
At close: Nov 6, 2026
BOM:500660 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, BOM:500660 stock has a consensus rating of "Buy" and an average price target of ₹3,097. The average 1-year stock price forecast is 22.67% higher than the current stock price, while the lowest is ₹2,900 (+14.86%) and the highest is ₹3,500 (+38.62%).
Price Target: ₹3,097 (+22.67%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BOM:500660 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
42.68B
from 38.22B
Increased by 11.68%
Revenue Next Year
47.34B
from 42.68B
Increased by 10.91%
EPS This Year
70.80
from 60.11
Increased by 17.78%
EPS Next Year
79.18
from 70.80
Increased by 11.83%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.